Deutschmann, C.; Heinzl, F.; Leser, C.; Gschwantler-Kaulich, D.; Singer, C.F.; Kostic, S.; Golescu, A.; Pfeiler, G.
Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis. J. Clin. Med. 2026, 15, 3433.
https://doi.org/10.3390/jcm15093433
AMA Style
Deutschmann C, Heinzl F, Leser C, Gschwantler-Kaulich D, Singer CF, Kostic S, Golescu A, Pfeiler G.
Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis. Journal of Clinical Medicine. 2026; 15(9):3433.
https://doi.org/10.3390/jcm15093433
Chicago/Turabian Style
Deutschmann, Christine, Florian Heinzl, Carmen Leser, Daphne Gschwantler-Kaulich, Christian F. Singer, Suncica Kostic, Adelheid Golescu, and Georg Pfeiler.
2026. "Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis" Journal of Clinical Medicine 15, no. 9: 3433.
https://doi.org/10.3390/jcm15093433
APA Style
Deutschmann, C., Heinzl, F., Leser, C., Gschwantler-Kaulich, D., Singer, C. F., Kostic, S., Golescu, A., & Pfeiler, G.
(2026). Is Genetic Testing of HER2-Negative Metastatic Breast Cancer Patients Implemented into Clinical Practice? A Retrospective Analysis. Journal of Clinical Medicine, 15(9), 3433.
https://doi.org/10.3390/jcm15093433
